What is the appropriate approach and treatment for hypotension?

Approach and Treatment of Hypotension

The approach to hypotension must be etiology-driven: immediately identify the underlying cause (hypovolemic, cardiogenic, distributive, or obstructive shock) through clinical assessment and targeted interventions, then initiate cause-specific treatment with fluid resuscitation and/or vasoactive agents while maintaining mean arterial pressure ≥60 mm Hg in at-risk patients.

Initial Assessment and Diagnosis

Immediate Clinical Evaluation

Rapidly assess the hemodynamic profile by examining:

• Blood pressure pattern: Low diastolic BP with preserved pulse pressure suggests distributive shock (vasodilation); narrow pulse pressure with high diastolic BP indicates cardiogenic or hypovolemic shock 1, 2
• Skin perfusion: Check capillary refill time, skin temperature, and mottling 3
• Jugular venous pressure: Low JVP suggests hypovolemia; elevated JVP indicates right ventricular infarction or cardiogenic shock 1
• Tissue perfusion markers: Mental status, urine output, lactate levels (target <2.0 mmol/L), and central venous oxygen saturation if available 3

Exclude Reversible Causes First

Before initiating vasoactive therapy, rule out:

• Hypovolemia (responds to fluid challenge)
• Vasovagal reactions
• Bradycardia-hypotension (responds to atropine)
• Medication effects (review and discontinue offending agents)
• Arrhythmias 1

Etiology-Specific Treatment Algorithms

Distributive Shock (Sepsis, Anaphylaxis)

For Septic Shock:

1. Norepinephrine is the first-line vasoactive agent after adequate fluid resuscitation, targeting MAP ≥65 mm Hg 2
2. Add vasopressin (up to 0.03 units/min) if hypotension persists despite norepinephrine 2
3. If myocardial depression is evident (low cardiac output with adequate filling pressures), add dobutamine to norepinephrine OR switch to epinephrine as single agent 2
4. Dopamine only if bradycardia present or low tachycardia risk 2
5. Phenylephrine reserved for salvage therapy only 2

For Anaphylaxis:

1. Epinephrine 0.3-0.5 mg IM (1:1000 dilution) into deltoid or lateral thigh immediately, repeat every 5 minutes as needed 4, 5
2. Place patient recumbent with legs elevated 4
3. Administer oxygen 6-8 L/min 4
4. Establish IV access and give rapid crystalloid infusion (1-2 L normal saline in adults at 5-10 mL/kg in first 5 minutes) 4
5. If severe hypotension persists after multiple IM doses, consider epinephrine infusion (1 mg in 250 mL D5W at 1-4 mcg/min) with continuous hemodynamic monitoring 4, 5
6. Secondary measures: chlorphenamine 10 mg IV, hydrocortisone 200 mg IV 5

Cardiogenic Shock

1. Inotropes are first-line (dobutamine 2.5-10 mcg/kg/min, or dopamine 2.5-5 mcg/kg/min if renal hypoperfusion) 1, 2
2. If persistent hypotension with tachycardia, add norepinephrine 2
3. If bradycardia present, use dopamine 2
4. Avoid beta-blockers and calcium channel blockers 6
5. Consider intra-aortic balloon pump if pharmacologic therapy fails 1, 6
6. Urgent revascularization (PCI or CABG) strongly recommended - improves survival 1, 6
7. In afterload-dependent states (aortic/mitral stenosis), use phenylephrine or vasopressin 2

Hypovolemic Shock

1. Rapid IV crystalloid bolus (normal saline or lactated Ringer's) 1, 7
2. Reassess after each bolus; continue until perfusion improves or signs of volume overload appear
3. If hypotension persists after adequate volume resuscitation, add vasopressor support 6
4. Address underlying cause (hemorrhage control, etc.)

Orthostatic Hypotension (Chronic Management)

Non-pharmacologic measures (first-line):

• Adequate salt (10 g/day) and fluid intake (2-3 L/day) 8
• Head-up tilt sleeping (10°) 8
• Compression stockings/abdominal binders 8, 9
• Physical counterpressure maneuvers (leg crossing, squatting) 8
• Discontinue or reduce offending medications 9, 10

Pharmacologic therapy (if non-pharmacologic measures insufficient):

• Midodrine 5-20 mg three times daily (alpha-1 agonist, FDA-approved) 8, 9, 11
• Droxidopa (FDA-approved for neurogenic orthostatic hypotension) 9, 12
• Fludrocortisone 0.1-0.3 mg once daily (if additional therapy needed) 8

Hemodynamic Targets and Monitoring

Blood Pressure Goals

• Maintain MAP ≥60 mm Hg in at-risk patients during acute management 2, 13
• Consider MAP ≥65 mm Hg in septic shock 2
• Increase MAP targets when venous or compartment pressures are elevated 13
• Individualize targets based on patient's baseline BP and comorbidities 2

Essential Monitoring Parameters

• Continuous arterial pressure monitoring preferred over intermittent cuff measurements in acute shock 13
• Serial lactate measurements (target clearance and normalization) 2, 3
• Urine output (target >0.5 mL/kg/hr)
• Central venous oxygen saturation (ScvO2) if central line present 3
• Cardiac output monitoring when available 2

Critical Pitfalls to Avoid

1. Do not delay epinephrine in anaphylaxis - it is the only life-saving intervention; there are no absolute contraindications 4
2. Avoid treating hypotension with vasopressors before adequate fluid resuscitation in hypovolemic states 2
3. Do not use beta-blockers or calcium channel blockers in cardiogenic shock 6
4. Avoid aggressive treatment of intraoperative hypertension as it commonly causes rebound hypotension 13
5. Recognize that postoperative hypotension is often unrecognized, prolonged, and untreated - may be more harmful than intraoperative hypotension 13
6. Do not rely solely on blood pressure - assess multiple perfusion markers (skin perfusion, lactate, urine output, mental status) 3
7. Phenylephrine should be reserved for salvage therapy in distributive shock due to potential for decreased cardiac output 2

Fluid Resuscitation Specifics

• Use balanced crystalloids (normal saline or lactated Ringer's) 4, 7
• In septic shock: may require large volumes (30 mL/kg or more) 4
• In cardiogenic shock: use cautiously, guided by hemodynamic monitoring (target wedge pressure <20 mm Hg) 1
• Titrate to clinical endpoints (improved perfusion markers), not fixed volumes 7, 3